What do we know about COVID-19 implications for cardiovascular disease?

806.8K

views

1005

authors

109

articles

Editorial

17 January 2023

Editorial: What do we know about COVID-19 implications for cardiovascular disease?

Zeyuan Wang

,

Muyun Tang

,

Xiaodong Luan

,

Hendrik Tevaearai Stahel

, 3 more and

Shuyang Zhang

1,507 views

1 citations

Editors

5

Hendrik Tevaearai Stahel

University Hospital of Bern

Masanori Aikawa

Brigham and Women's Hospital, Harvard Medical School

Shuyang Zhang

Department of Cardiology, Peking Union Medical College Hospital (CAMS)

Mingxing Xie

Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Shuping Ge

St. Christopher's Hospital for Children

Impact

Fetching...

About

Download the ebooks for this Research Topic:
Volume I.A: ¦PDF¦
¦EPUB

Volume I.B: ¦PDF¦
¦EPUB

The coronavirus epidemic is a major concern for each one of us, whether we figure among the regular citizens, those affected by the disease, or those involved in their treatment. Much has already been said, however, there is still a lack of profound understanding regarding specific situations, such as the interaction between the virus and the cardiovascular system.

We have read that elderly people with coronary artery disease, diabetes or hypertension as well as those with a history of stroke may have a higher risk of being infected, seem to be more severely affected than other persons, and have a higher mortality rate. But other infections, flus and stress situations have previously been shown to also affect the risk and prognosis of patients with cardiovascular disease, through myocarditis, arrhythmias, acute coronary syndromes, acute heart failure or cardiogenic shock.

The Research Topic aims at answering the following questions:
1) What is different with the COVID-19 virus? What have we learned so far and what did we know from previous epidemics, especially the recent SARS-CoV and MERS-CoV epidemics?
2) How can we best manage and monitor cardiovascular patients affected by the COVID-19 virus? For instance, should patients with cardiovascular disease get a higher priority when diagnosed with the COVID-19?
3) How can computational analysis help to assess the risk of COVID-19 in cardiovascular disease?
4) How can a systems approach explore mechanisms for cardiovascular complications of COVID-19?
5) How does COVID-19 affect immunity and inflammation?
6) Does this virus attack cardiovascular cells/organs?
7) What is the role of cardiovascular imaging in the diagnosis and management of COVID-19 patients, and how can multimodality imaging be used in the evaluation of cardiovascular complications in patients with COVID-19?

Other aspects are also critical to be presented and discussed and include:
1) The mechanisms of interaction of the disease with ACE inhibitors, angiotensin blockers and possibly other drugs used to treat cardiovascular patients.
2) The current knowledge from laboratory and preclinical studies.
3) The effect of the virus in patients with congenital heart disease.
4) The current challenges for a general cardiologist, the challenge for those practicing specialized interventions and for cardiovascular surgeons, the challenge of practicing CPR, etc.
5) The recommendations regarding physical activity and rehabilitation of patients after a cardiovascular event.
6) The particularities of specific countries or regions.
7) The role of government, academia, and industry and their interactions.
8) Possible other challenges.
9) Possible opportunities that can result from this crisis.

The Editors invite all clinicians and scientists around the world dealing with cardiovascular disease to submit their original manuscripts, reviews, opinion and case reports on the topic. Considering the urgency of the situation, all submissions will be reviewed with a high priority aiming at speeding up the dissemination of our current knowledge.

Download ebook

PDF

EPUB

Share

Editors

Hendrik Tevaearai Stahel

University Hospital of Bern

Masanori Aikawa

Brigham and Women's Hospital, Harvard Medical School

Shuyang Zhang

Department of Cardiology, Peking Union Medical College Hospital (CAMS)

Mingxing Xie

Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Shuping Ge

St. Christopher's Hospital for Children

Impact

806,789 Total views

633,425 Article views

153,331 Article downloads

20,033 Topic views

Published In

Frontiers in Cardiovascular Medicine

Heart Valve Disease, Sex and Gender in Cardiovascular Medicine, Cardiovascular Epidemiology and Prevention, Cardiovascular Imaging, Cardiovascular Surgery, Hypertension, Cardiovascular Genetics and Systems Medicine, Cardiac Rhythmology, General Cardiovascular Medicine, Heart Failure and Transplantation, Cardiovascular Biologics and Regenerative Medicine, Atherosclerosis and Vascular Medicine, Cardiovascular Metabolism, Coronary Artery Disease, Thrombosis and Haemostasis, Structural Interventional Cardiology, Cardio-Oncology

Frontiers in Surgery

Cardiovascular Surgery

Frontiers in Oncology

Cardio-Oncology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic